EyePoint at TD Cowen Conference: DURAVYU’s Market Potential

Entity Intersection Graph

No entity connections available yet for this article.

}

Original Source

              On Tuesday, 03 March 2026, EyePoint Pharmaceuticals (NASDAQ:EYPT) participated in the TD Cowen 46th Annual Health Care Conference. The company provided a strategic overview of its clinical trials for DURAVYU, highlighting both its promising potential in treating diabetic macular edema and wet age-related macular degeneration , as well as the challenges of market underappreciation. The conference emphasized EyePoint’s focus on innovative treatment approaches and its strategic plans for future growth.
            

Read full article at source